Autori: Vrdoljak Eduard
Naslov | Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe (Article) |
Autori | Vrdoljak Eduard ... Tomasevic Zorica I ... (broj koautora 16) |
Info | ONCOLOGIST, (2019), vol. 24 br. 1, str. E30-E37 |
Projekat | Roche |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer (Article) |
Autori | Kim Tae Won Elme Anneli Park Joon Oh Udrea Anghel Adrian Kim Sun Young Ahn Joong Bae Valencia Ricardo Villalobos Krishnan Srinivasan Manojlovic Nebojsa S Guan Xuesong Lofton-Day Catherine Jung A Scott Vrdoljak Eduard |
Info | CLINICAL COLORECTAL CANCER, (2018), vol. 17 br. 3, str. 206-214 |
Projekat | Amgen Inc |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement (Article) |
Autori | Vrdoljak Eduard ... Tomasevic Zorica I ... (broj koautora 17) |
Info | ONCOLOGIST, (2016), vol. 21 br. 10, str. 1183-1190 |
Projekat | Roche |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |